B
IMUX icon

Braidwell’s Immunic IMUX Stock Holding History

Braidwell’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.91M Buy
+645,010
New +$7.96M 0.37% 71

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Braidwell's IMUX Position: Q2 2026 in Review

Braidwell opened a new position in Immunic (IMUX) in Q2 2026: 645,010 shares worth $9.91M. The stake represents 0.37% of the portfolio and ranks #71 among its holdings.

54 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Braidwell held 645,010 shares of Immunic worth $9.91M as of Q2 2026.
  • Immunic was a new Braidwell position in Q2 2026.
  • Immunic made up 0.37% of Braidwell's portfolio in Q2 2026, its #71 holding.
  • 54 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.